Latest Licensing News

AdAlta Limited has made significant progress in its 'East to West' cellular immunotherapy strategy, advancing licensing negotiations for its first CAR-T product and raising $1.6 million through placements to bolster its financial position.

Algorae Pharmaceuticals has broadened its commercial footprint in Australia and New Zealand through key licensing agreements, while advancing its AI-driven drug discovery platform and strengthening leadership.

Starpharma has secured two major partnership agreements with Genentech and Radiopharm Theranostics, unlocking significant upfront payments and milestone potential while advancing its clinical pipeline.

White Cliff Minerals has confirmed sediment-hosted copper mineralisation at its Rae Copper Project in Nunavut, Canada, with diamond drilling revealing multiple copper styles and promising grades. The discovery points to a fertile system with clear pathways to higher-grade zones.

Black Rock Mining has secured A$14 million through a placement and oversubscribed share purchase plan to kickstart early construction at its Mahenge Graphite Project in Tanzania, backed by strong government and industry support.

Credit Corp Group has reaffirmed its FY26 guidance, highlighting robust earnings growth driven by operational improvements across its US debt buying and Australian/New Zealand lending segments.

Canadian Phosphate Limited has bolstered its balance sheet through the sale of its pelleting plant and reported improved cash flow despite permitting setbacks in British Columbia. The company is strategically positioned to capitalize on growing North American demand for domestically sourced phosphate amid global supply disruptions.

Brazilian Critical Minerals has reported exceptional results from its in-situ recovery trials at the Ema rare earth project, achieving rare earth concentrations far exceeding in-situ grades and securing strong local government backing.

Cambium Bio has locked in a significant R&D tax rebate and forged three strategic partnerships, underpinning its Phase 3 clinical trials for its lead ophthalmology biologic. The company’s recent capital raise further strengthens its runway as it prepares for pivotal trial milestones.

Proteomics International Laboratories has secured ISO 15189 certification and launched PromarkerD and PromarkerEso nationally in Australia, while advancing US reimbursement pathways and preparing for leadership transition.

Manhattan Corporation reveals exceptional surface assay results from its Hook Lake Project in Nunavut, highlighting untapped high-grade gold and silver mineralisation at the Quantum and Lotus prospects. The company plans maiden drilling in 2026 to further explore these promising targets beyond the known Jaws deposit.

First Au Limited has struck a deal granting AustChina Holdings an exclusive 19-month option to acquire its Eastern Victorian Goldfield Project, unlocking value from a non-core asset while sharpening focus on its African and Western Australian ventures.